(iii) The effects of miR-590-5p on plaque angiogenesis should be studied in animal model of dyslipidemia (for example, Apo-E or LDLr null mice) to determine the effects of this microRNA in targeting a specific disease state. Here, LDLR is linked to metabolic syndrome.